Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

Around 2 to 3 million people live with hepatitis C in the U.S. and 40% of those people (roughly 800,000) were not even aware ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

In 2023 Cullgen completed a Series C financing led by AstraZeneca-CICC Venture Capital Partnership, and also announced a strategic partnership with Astellas Pharma Inc.

A new poll shows that nearly one in 10 adults has had a family member die of a drug overdose. Dealing with the loss can be ...

One study suggests these drugs could increase depression risk in heart attack survivors who retained normal heart pumping ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...